Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.1B | 981M | 810M | 860M |
Cost of revenue | 312M | 286M | 235M | 275M |
Gross profit | 773M | 695M | 575M | 585M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 109M | 112M | 98M | 145M |
Other operating expenses | — | 6M | 177M | 64M |
Operating income | 462M | 379M | 103M | 178M |
Non operating interest income | ||||
Income | 14M | 19M | 19M | 19M |
Expense | 125M | 128M | 128M | 125M |
Other income expense | -44M | -62M | 22M | 14M |
Pretax income | 307M | 206M | 16M | 86M |
Tax provision | 68M | 39M | 2M | 21M |
Net income | 239M | 167M | 14M | 65M |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 609M | 627M | 316M | 391M |
Net income from continuing op. | 239M | 167M | 14M | 65M |
Minority interests | -3M | -3M | -2M | -3M |
Preferred stock dividends | — | — | — | — |